A correlation between the incorporation of formate-C14 in tumors and the clinical course of patients with disseminated breast cancer
β Scribed by Sydney Kofman; Howard H. Sky-Peck; Charles P. Perlia; Steven G. Economou; Richard J. Winzler; Samuel G. Taylor III
- Publisher
- John Wiley and Sons
- Year
- 1960
- Tongue
- English
- Weight
- 544 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Delayed cutaneous hypersensitivity reactions to DNCB were performed before therapy i n 84 patients with recurrent breast cancer. Following sensitization, a lW+g challenge dose was graded as a strong, weak, or negative reaction. Thirty six patients were rechallenged 2 6 months with 100 +g of DNCB. Pa
Immunoregulatory factor (IRF) is a 70,000 molecular weight glycoprotein produced by human tumors that suppresses lymphocyte function including mitogen-stimulated tritiated leucine ('H-leu) and tritiated thymidine (3H-Tdr) uptake, in vitro immunoglobulin synthesis, induction of allospecific cell-medi